Our intestines naturally secrete GLP-1 when we eat, which sends signals to our pancreas to produce more insulin
One of the concerns with any rapid weight loss, whether from GLP-1 medications, calorie restriction, or surgery, is the loss of lean body mass alongside fat
They think, works in the gut, decreases your appetite
Start your intake Understanding GLP-1 Medications and MS-Specific Concerns GLP-1 receptor agonists like Ozempic (semaglutide) work by slowing gastric emptying, increasing insulin secretion, and signaling satiety in the brain
The peptide CDMO market, valued at approximately $4.14 billion in 2025, is forecast to reach $9.84 billion by 2031 at a compound annual growth rate of 15.5%
The unit count depends on your vial's concentration